KRAS and colorectal carcinoma: KRAS, a more frequent mutation than BRAF in CRC is mostly distributed along the proximal-distal axis of the colorectum, has little prognostic value as compared to BRAF in overall patient survival and a mutation more likely to develop on the right of the colon.